Network-based analysis and characterization of adverse drug-drug interactions

Journal of Chemical Information and Modeling

Volumn 51, Issue 11, 2011, Pages 2977-2985

  Takarabe, Masataka ^a   Shigemizu, Daichi ^a   Kotera, Masaaki ^a   Goto, Susumu ^a   Kanehisa, Minoru ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ENGINEERING; CHEMISTRY;

ACTIVE INGREDIENTS; CLASSIFICATION SYSTEM; DRUG-DRUG INTERACTIONS; DRUG-METABOLIZING ENZYMES; HEALTH PROFESSIONALS; INTERACTION PATTERN; NETWORK-BASED ANALYSIS; PRESCRIPTION DRUGS;

DRUG INTERACTIONS;

PRESCRIPTION DRUG;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; CHEMISTRY; DATA MINING; DRUG ANTAGONISM; DRUG COMBINATION; DRUG DELIVERY SYSTEM; DRUG TOXICITY; FACTUAL DATABASE; HUMAN; JAPAN; METABOLISM; METHODOLOGY;

ALGORITHMS; CHEMISTRY, PHARMACEUTICAL; DATA MINING; DATABASES, FACTUAL; DRUG ANTAGONISM; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; DRUG TOXICITY; HUMANS; JAPAN; NEURAL NETWORKS (COMPUTER); PRESCRIPTION DRUGS;

EID: 82355160710     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci200367w     Document Type: Article

References (42)

1. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs Nucleic Acids Res. 2010, 38, 355-360
2. Chan, T. Y. Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance Ann. Pharmacother. 1995, 29, 1274-1283 (Pubitemid 26044867)
3. Juurlink, D. N.; Gomes, T.; Ko, D. T.; Szmitko, P. E.; Austin, P. C.; Tu, J. V.; Henry, D. A.; Kopp, A.; Mamdani, M. M. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel CMAJ 2009, 180, 713-718
4. Burman, W. J.; Gallicano, K.; Peloquin, C. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis Clin. Infect. Dis. 1999, 28, 419-429
5. Juurlink, D. N.; Mamdani, M.; Kopp, A.; Laupacis, A.; Redelmeier, D. A. Drug-drug interactions among elderly patients hospitalized for drug toxicity JAMA 2003, 289, 1652-1658 (Pubitemid 37430270)
6. Sikka, R.; Magauran, B.; Ulrich, A.; Shannon, M. Bench to bedside: pharmacogenomics, adverse drug interactions, and the cytochrome P450 system Acad. Emerg. Med. 2005, 12, 1227-1235 (Pubitemid 41681176)
7. Wienkers, L. C.; Heath, T. G. Predicting in vivo drug interactions from in vitro drug discovery data Nat. Rev. Drug Discovery 2005, 4, 825-833 (Pubitemid 41553963)
8. Spina, E.; Santoro, V.; D'Arrigo, C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update Clin. Ther. 2008, 30, 1206-1227
9. Tallarida, R. J. Drug synergism: its detection and applications J. Pharmacol. Exp. Ther. 2001, 298, 865-872 (Pubitemid 32761897)
10. Luo, H.; Chen, J.; Shi, L.; Mikailov, M.; Zhu, H.; Wang, K.; He, L.; Yang, L. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome Nucleic Acids Res. 2011, 39, 492-498
11. Campillos, M.; Kuhn, M.; Gavin, A. C.; Jensen, L. J.; Bork, P. Drug target identification using side-effect similarity Science 2008, 321, 263-266 (Pubitemid 351989100)
12. Newcombe, R. G. Interval estimation for the difference between independent proportions: comparison of eleven methods Stat. Med. 1998, 30, 873-890 (Pubitemid 28185166)
13. Rice, W. R. Analyzing tables of statistical tests Evolution 1989, 43, 223-225
14. Rohrer, D. K.; Kobilka, B. K. G protein-coupled receptors: functional and mechanistic insights through altered gene expression Physiol. Rev. 1998, 78, 35-52 (Pubitemid 28070974)
15. Marinissen, M. J.; Gutkind, J. S. G-protein-coupled receptors and signaling networks: emerging paradigms Trends Pharmacol. Sci. 2001, 22, 368-376 (Pubitemid 32592476)
16. Insel, P. A.; Tang, C. M.; Hahntow, I.; Michel, M. C. Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets Biochim. Biophys. Acta 2007, 1768, 994-1005 (Pubitemid 46452544)
17. Liu, Y. H.; Xu, J.; Yang, X. P.; Yang, F.; Shesely, E.; Carretero, O. A. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure Hypertension 2002, 39, 375-381 (Pubitemid 34165152)
18. Anadón, A.; Reeve-johnson, L. Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine Res. Vet. Sci. 1999, 66, 197-203 (Pubitemid 29263726)
19. Zhou, S. F. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4 Curr. Drug Metab. 2008, 9, 310-322
20. Allington, D. R.; Rivey, M. P. Quinupristin/dalfopristin: a therapeutic review Clin. Ther. 2001, 23, 24-44 (Pubitemid 32113620)
21. Weiner, I. D.; Wingo, C. S. Hyperkalemia: a potential silent killer J. Am. Soc. Nephrol. 1998, 9, 1535-1543 (Pubitemid 28354566)
22. Eichhorn, E. J.; Gheorghiade, M. Digoxin Prog. Cardiovasc. Dis. 2002, 44, 251-266 (Pubitemid 34438285)
23. Bizjak, E. D.; Mauro, V. F. Digoxin-macrolide drug interaction Ann. Pharmacother. 1997, 31, 1077-1079 (Pubitemid 27390965)
24. Yagiela, J. A. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors. Part V of a series J. Am. Dent. Assoc. 1999, 130, 701-709
25. Andrews, R. C.; Walker, B. R. Glucocorticoids and insulin resistance: old hormones, new targets Clin. Sci. 1999, 96, 513-523 (Pubitemid 29237902)
26. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Recomm. Rep. 1993, 42, 1-18.
27. Steele, R. W. Current status of vaccines and immune globulins for children with renal disease Pediatr. Nephrol. 1994, 8, 7-10 (Pubitemid 24042357)
28. Piper, J. M.; Ray, W. A.; Daugherty, J. R.; Griffin, M. R. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs Ann. Intern. Med. 1991, 114, 735-740
29. Field, M. J.; Giebisch, G. J. Hormonal control of renal potassium excretion Kidney Int. 1985, 27, 379-387 (Pubitemid 15142690)
30. Kraft, M. D.; Btaiche, I. F.; Sacks, G. S.; Kudsk, K. A. Treatment of electrolyte disorders in adult patients in the intensive care unit Am. J. Health Syst. Pharm. 2005, 62, 1663-1682 (Pubitemid 41153661)
31. Nakadate, T.; Nakaki, T.; Muraki, T.; Kato, R. Adrenergic regulation of blood glucose levels: possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release J. Pharmacol. Exp. Ther. 1980, 215, 226-230 (Pubitemid 11102279)
32. DiTullio, N. W.; Cieslinski, L.; Matthews, W. D.; Storer, B. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists J. Pharmacol. Exp. Ther. 1984, 228, 168-173 (Pubitemid 14223397)
33. Haupt, D. W.; Newcomer, J. W. Hyperglycemia and antipsychotic medications J. Clin. Psychiatry 2001, 62, 15-26 (Pubitemid 34052253)
34. Luna, B.; Feinglos, M. N. Drug-induced hyperglycemia JAMA 2001, 286, 1945-1948 (Pubitemid 33010204)
35. Jacob, S.; Rett, K.; Henriksen, E. J. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? Am. J. Hypertens. 1998, 11, 1258-1265
36. Houston, M. C. Nonsteroidal anti-inflammatory drugs and antihypertensives Am. J. Med. 1991, 90, 42-47
37. Sartori, A. M. A review of the varicella vaccine in immunocompromised individuals Int. J. Infect. 2004, 8, 259-270 (Pubitemid 39119849)
38. Lawson, D. H.; Macadam, R. F.; Singh, M. H.; Gavras, H.; Hartz, S.; Turnbull, D.; Linton, A. L. Effect of furosemide on antibiotic-induced renal damage in rats J. Infect. Dis. 1972, 126, 593-600
39. Barza, M. The nephrotoxicity of cephalosporins: an overview J. Infect. Dis. 1978, 137, 60-73
40. Tune, B. M. Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention Pediatr. Nephrol. 1997, 11, 768-772 (Pubitemid 27520549)
41. Hasfurther, D. L.; Bailey, P. L. Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin Can. J. Anaesth. 1996, 43, 617-620 (Pubitemid 26291290)
42. Naguib, M.; Magboul, M. M.; Samarkandi, A. H.; Attia, M. Adverse effects and drug interactions associated with local and regional anaesthesia Drug Saf. 1998, 18, 221-250 (Pubitemid 28177289)